Rejuvenate your skin with this ‘proven’ Aussie skincare range14 Sep 2020
Hyperpigmentation is a broad term used to describe concentrated areas of skin that become discoloured due to excess melanin production.
Often harmless and limited to the face, neck, hands and chest, most common forms of hyperpigmentation include solar lentigines, also known as sun, age or liver spots; and melasma, or “the mask of pregnancy”.
Although people of any age, sex and race can develop this condition, it is more prevalent in women of lighter skin tone. This is usually attributed to a host of environmental and hormonal factors, including unprotected sun exposure, medications, and increased oestrogen levels.
While treatment options can include intense pulsed light (IPL), cosmetic surgery and dermabrasion, tyrosinase inhibition is proven to be the most effective and safest treatment to date.
Offering a gentle and superior alternative to hydroquinone-based formulations, Enlighten by Evidence Skincare (ESK) uses a relatively new tyrosinase-inhibitor, 4-n-Butylresorcinol (4nB), to lighten skin and reduce future melanin deposits.
Fast results with less skin irritation
Pronounced “4-n-beautal-resorcinol”, 4nB has been proven to be the most effective depigmenting agent when compared to industry alternatives such as hydroquinone, arbutin, azelaic acid, and kojic acid, and produce faster results in as little six weeks with less skin irritation.
Formulated with sensitive skin types in mind, Enlighten combines 4nB with antioxidant multitasker, niacinamide (vitamin B3), to help regulate normal skin cell function, improve the skin’s moisture barrier, and reduce the transfer of melanin to keratinocytes where pigment is deposited.
In addition to its hyperpigmentation benefits, Enlighten is also shown to help balance sebum production, increase collagen synthesis, and reduce post-inflammatory redness.
Paired with other active ingredients
Suitable for daily and long-term use, Enlighten can be paired with other active ingredients, such as vitamin C and alpha hydroxy acids, for enhanced depigmentation and overall skin rejuvenation.
Australian-made and owned Evidence Skincare (ESK) was co-founded by health expert Dr Ginni Mansberg, a regular guest on Seven’s Sunrise and one of the former hosts of medical program, Embarrassing Bodies Down Under.
Dr Mansberg worked with doctors, dermatologists and scientists, to create a skincare range that is “evidence based, effective, easy to use and ethical.”
The products were originally only available through medical practitioners but are now available globally to everyone.
Evidence Skincare (ESK), Enlighten retails for $95 RRP (50g).